STAUCH; Oliver Boris

Patent Applications and Registrations

Patent applications and USPTO patent grants for STAUCH; Oliver Boris.The latest application filed is for "high concentration antibody-containing liquid formulation".

Company Profile

1.10.22

STAUCH; Oliver Boris - Freiburg DE
Stauch; Oliver Boris - Mountain View CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Concentration Antibody-containing Liquid Formulation App 20220281988 - MORICHIKA; Toshiyuki ; et al.	2022-09-08
High concentration antibody-containing liquid formulation Grant 11,359,026 - Morichika , et al. June 14, 2	2022-06-14
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof App 20210353753 - Adler; Michael ; et al.	2021-11-18
High Concentration Antibody-containing Liquid Formulation App 20210246216 - MORICHIKA; Toshiyuki ; et al.	2021-08-12
High concentration antibody-containing liquid formulation Grant 11,008,394 - Morichika , et al. May 18, 2	2021-05-18
Highly Concentrated Pharmaceutical Formulations App 20210054092 - Adler; Michael ; et al.	2021-02-25
Highly concentrated pharmaceutical formulations Grant 10,752,696 - Adler , et al. A	2020-08-25
High Concentration Antibody-containing Liquid Formulation App 20200079857 - MORICHIKA; Toshiyuki ; et al.	2020-03-12
Highly Concentrated Pharmaceutical Formulations App 20190367629 - Adler; Michael ; et al.	2019-12-05
Highly concentrated pharmaceutical formulations Grant 10,377,831 - Adler , et al. A	2019-08-13
Highly concentrated pharmaceutical formulations Grant 10,280,227 - Adler , et al.	2019-05-07
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof App 20180228895 - Adler; Michael ; et al.	2018-08-16
Subcutaneous anti-HER2 antibody formulations and uses thereof Grant 9,968,676 - Adler , et al. May 15, 2	2018-05-15
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof App 20160166689 - Adler; Michael ; et al.	2016-06-16
Subcutaneous anti-HER2 antibody formulations and uses thereof Grant 9,345,661 - Adler , et al. May 24, 2	2016-05-24
Highly Concentrated Pharmaceutical Formulations App 20160137742 - Adler; Michael ; et al.	2016-05-19
High Concentration Antibody-containing Liquid Formulation App 20160090419 - MORICHIKA; Toshiyuki ; et al.	2016-03-31
Highly Concentrated Pharmaceutical Formulations App 20150086537 - Adler; Michael ; et al.	2015-03-26
Pharmaceutical Formulation Comprising An Antibody Against P-selectin And A Sugar Selected From Sucrose And Trehalose App 20140093512 - Grauschopf; Ulla ; et al.	2014-04-03
High Concentration Antibody-containing Liquid Formulation App 20140005367 - MORICHIKA; Toshiyuki ; et al.	2014-01-02
Drug Reconstitution And Delivery Device App 20130296807 - Lintern; Richard ; et al.	2013-11-07
High concentration antibody-containing liquid formulation Grant 8,568,720 - Morichika , et al. October 29, 2	2013-10-29
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof App 20130216532 - Adler; Michael ; et al.	2013-08-22
Formulation Comprising An Antibody Against P-selectin App 20130209478 - Grauschopf; Ulla ; et al.	2013-08-15
Formulation Comprising An Antibody Against P-selectin App 20120321638 - Grauschopf; Ulla ; et al.	2012-12-20
Highly Concentrated Pharmaceutical Formulations App 20110076273 - Adler; Michael ; et al.	2011-03-31
Subcutaneous anti-HER2 antibody formulations and uses thereof App 20110044977 - Adler; Michael ; et al.	2011-02-24
High Concentration Antibody-containing Liquid Formulation App 20100285011 - Morichika; Toshiyuki ; et al.	2010-11-11
Novel Antibody Formulation App 20100074903 - Grauschopf; Ulla ; et al.	2010-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.